A prospective randomized control study of combination therapy with low-dose methimazole and a cholesterol absorption inhibitor as for the initial treatment of childhood-onset Graves disease
Not Applicable
- Conditions
- Graves disease
- Registration Number
- JPRN-UMIN000014383
- Lead Sponsor
- ABC Tx group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients with thyrotoxic crisis 2)Patients who receive pharmacotherapy for diabetes, hepatic and renal disease 3)Medical history of Graves disease. Patients who have already used cholesterol absorption inhibitor. 4)Use of coumarin anticoagulants, digitalis, and bile acids preparations 5)Judged inappropriate for this study by the physicians.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method